Ginger and Cancer: Research Status
Ginger is a subject of research in preventive oncology. Here's what studies show — and their limitations.
Studied Anti-cancer Mechanisms
| Mechanism | Active Compound | Research Stage |
|---|---|---|
| NF-κB Inhibition | 6-gingerol | In vitro + animal |
| Cell Apoptosis | 6-shogaol | In vitro |
| Anti-angiogenesis | Zerumbone | In vitro + animal |
| Anti-proliferation | 6-gingerol | In vitro |
Important Limitations
The majority of studies are in vitro (in the laboratory) or on animal models. Large-scale human clinical trials are still lacking. Ginger is not a cancer treatment — it is a food with bioactive properties currently under study.
The Role of Inflammation
Chronic inflammation is a recognized factor in carcinogenesis. Ginger, by inhibiting NF-κB and COX-2, acts on this inflammatory ground. But sugar activates NF-κB, potentially canceling this effect.
INTI — ginger + turmeric + turmeric-2026">black pepper, zero added sugar. Always consult your oncologist.